Explore

Trendline Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Trendline Trendline
Soligenix Reports Financial Results and Updates on Clinical Trials

Soligenix Reports Financial Results and Updates on Clinical Trials

Soligenix Reports Financial Results and Updates on Clinical Trials
Trendline Trendline
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand

Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand

Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Trendline Trendline
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges

Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges

Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Trendline Trendline
Stoke Therapeutics Reports Q1 2026 Financial Results and Advances Dravet Syndrome Treatment

Stoke Therapeutics Reports Q1 2026 Financial Results and Advances Dravet Syndrome Treatment

Stoke Therapeutics Reports Q1 2026 Financial Results and Advances Dravet Syndrome Treatment
Trendline Trendline
BioLife Solutions Reports Strong Q1 2026 Financial Performance with 25% Revenue Growth

BioLife Solutions Reports Strong Q1 2026 Financial Performance with 25% Revenue Growth

BioLife Solutions Reports Strong Q1 2026 Financial Performance with 25% Revenue Growth
Trendline Trendline
Rocket Pharmaceuticals Advances Gene Therapy Pipeline with FDA Engagement and Financial Strength

Rocket Pharmaceuticals Advances Gene Therapy Pipeline with FDA Engagement and Financial Strength

Rocket Pharmaceuticals Advances Gene Therapy Pipeline with FDA Engagement and Financial Strength
Trendline Trendline
Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Trendline Trendline
AbCellera to Present at Major Investor Conferences in May and June 2026

AbCellera to Present at Major Investor Conferences in May and June 2026

AbCellera to Present at Major Investor Conferences in May and June 2026
Trendline Trendline
Janux Therapeutics Reports Q1 2026 Financial Results and Business Developments

Janux Therapeutics Reports Q1 2026 Financial Results and Business Developments

Janux Therapeutics Reports Q1 2026 Financial Results and Business Developments
Trendline Trendline
Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development

Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development

Quantum-Si Reports First Quarter 2026 Financial Results and Advances Proteus Development